Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus

Código QR

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus

This article addresses possible mechanisms for development of cardiovascular events (CVE) in type 2 diabetes mellitus (T2DM) patients treated with sulfonylurea derivatives (SU). Several problems are highlighted in this review, including molecular aspects of pancreatic and extrapancreatic action of t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Lyudmila Viktorovna Nedosugova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2013
Materias:	type 2 diabetes mellitus sulfonylureas sur katp channel ischemic preconditioning Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/819541cfb8404b78a7efb9920250ac0f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Sulfonylureas in the modern strategy of therapy of type 2 diabetes
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011)

Glibenclamide - profile of efficacy and safety
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
por: Alla Vsevolodovna Rudakova
Publicado: (2011)

The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
por: Aleksey Vadimovich Zilov, et al.
Publicado: (2010)

Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
por: Andrey Olegovich Emel'yanov, et al.
Publicado: (2009)

Type 2 diabetes therapy at the time of diagnosis. Glimepiride: property, efficiency, safety
por: Olga Mikhailovna Smirnova
Publicado: (2009)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)

MODY3 in the child with type 2 diabetes mellitus phenotype: case report
por: Tamara Leonidovna Kuraeva, et al.
Publicado: (2013)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Correlation between plasma proBNP, echocardiographic and clinical parameters in patientswith type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

The role of phenofibrate in the treatment of microvascular complications of type 2 diabetes mellitus
por: Larisa Viktorovna Koshel', et al.
Publicado: (2009)

Integrated surgical management of neuroischemic diabetic foot syndrome, abdominal aortic aneurysm and renal artery lesionsin patients with diabetes mellitus type 2
por: Sergey Anatol'evich Terekhin, et al.
Publicado: (2011)

Age and sex-related variations in the time of manifestation of type 1 diabetes mellitus and its chronic complications in children
por: Oleg Avgustovich Dianov, et al.
Publicado: (2010)

Economic evaluation of type 2 diabetes mellitus burden and its main cardiovascular complications in the Russian Federation
por: Ivan I. Dedov, et al.
Publicado: (2016)

The role of compensation of carbohydrate metabolism in pregnant women with type 1 diabetes mellitus in the development of perinatal complications
por: Roza Mikhailovna Esayan, et al.
Publicado: (2009)

Characteristics of natural history of diabetes mellitus, manifested after Cushing disease treatment
por: Elena Viktorovna Peretokina, et al.
Publicado: (2012)

Epidemiology of diabetes mellitus and microvascular complications
por: Oksana Vladimirovna Maslova, et al.
Publicado: (2011)

Metformin in patients with ischemic heart disease and type 2 diabetes mellitus: mechanism of action and clinical efficiency
por: Ekaterina Nikodimovna Kravchuk, et al.
Publicado: (2013)

Attitudes in patients with diabetes mellitus type 1 and type 2
por: Oleg Gennad'evich Motovilin, et al.
Publicado: (2012)

Diabetes mellitus type 2 in adults
por: Ivan I. Dedov, et al.
Publicado: (2020)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

Diabetes mellitus type 1 in adults
por: Ivan I. Dedov, et al.
Publicado: (2020)

Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
por: Olga Konstantinovna Vikulova
Publicado: (2012)

bFGF and TGFbeta1 growth factors, inflammatory markers (IL-6, TNF-alpha, CRP) and advanced glycation end-products (AGE, RAGE) in patients with ischemic heart disease and type 2 diabetes mellitus
por: Ekaterina Vladimirovna Ivannikova, et al.
Publicado: (2013)

Neuropsychological dynamics in patients with type 2 diabetes mellitus undergone coronary artery bypass grafting
por: Olga Alexandrovna Trubnikova, et al.
Publicado: (2012)

Diabetes mellitus type 2: a new indication for hypercortisolism screening?
por: Natalya Ivanovna Volkova, et al.
Publicado: (2012)

«DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator
por: Marina V. Shestakova, et al.
Publicado: (2021)

Adherence to medicamentous therapy of type 2 diabetes mellitus: results of patient questionnaires
por: Elena Viktorovna Surkova, et al.
Publicado: (2009)

Urinary excretion of type IV collagen as an early marker of renal fibrosis in patients with diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011)

Current state-of-the-art in the safe and efficient management of type 2 diabetes mellitusKey words: diabetes mellitus, vascular complications, glycemia control, management of diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2009)

Diabetes mellitus type 1 in childhood
por: Valentina A. Peterkova, et al.
Publicado: (2020)

Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2016)

Molecular and morphological peculiarities of chronic placental insufficiency formation caused by different types of diabetes mellitus
por: Tatyana G. Tral, et al.
Publicado: (2020)

Some mechanisms of inflammation development in type 2 diabetes mellitus
por: L. A. Bochkareva, et al.
Publicado: (2021)

Factors promoting development of renal tubulointerstitial lesions in patients with diabetes mellitus
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2010)

The role of the gut microbiota in the development of type 1 diabetes mellitus
por: L. I. Ibragimova, et al.
Publicado: (2021)

Immunological predictors of type 1 diabetes mellitus (literature review)
por: K. G. Korneva, et al.
Publicado: (2021)

Ischaemic heart disease in patients with diabetes mellitus and critical lower limb ischemia
por: Konstantin Vladimirovich Melkozerov, et al.
Publicado: (2012)

Efficacy of complex pathogenic therapy of diabetic distal neuropathy in patients with type 2 diabetes mellitus
por: Inessa I. Dubinina, et al.
Publicado: (2016)